β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Significance: Nicotine addiction that results from long-term smoking is a worldwide health epidemic. Here we show that nicotinic receptors containing specific subunits, located in the brain reward system, mediate the experience of both the acute rewarding and aversive effects of nicotine, depending on which neurons they are located. These results provide contradictory evidence to the popularly held belief that the brain dopaminergic system exclusively mediates the rewarding effects of abused drugs, instead providing evidence that the aversive motivational effects of nicotine are signaled through this system as well. Our results lead to a better understanding of the neurobiological substrates of nicotine reward and aversion and thus may lead to new possible targets for pharmacotherapeutic treatments of tobacco addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning
Tsai, H.-C., Zhang, F., Adamantidis, A., Stuber, G. D., Bonci, A., de Lecea, L., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1168878 · Cited by 1,266 · cited 8×
“13) using a gene transfer expression strategy combining lentiviral delivery and the Cre/loxP recombination system to double-dissociate the CPP and conditioned place aversion (CPA) for acute nicotine in nondependent mice.”
BackgroundInfluentialGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · cited 1×
“Intra-VTA self-administration leads to multiple doses of nicotine in 1 session (which likely leads to different amounts of nicotine in the VTA than the systemic dose used in the present study) that is repeated over many sessions, which may lead to tolerance effects after repeated activation of nAChRs expressed only wi…”
BackgroundHabenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 4×
“nAChRs are pentameric, ligand-gated ion channels that contain various combinations of subunits, designated α2-α10 and β2-β4, that bind acetylcholine and nicotine (11).”
BackgroundInfluentialGrace, A. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.1.x · Cited by 433
Hierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors
Mameli-Engvall, M., Evrard, A., Pons, S., Maskos, U., Svensson, T. H., Changeux, J.-P., & Faure, P. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.007 · Cited by 296
Self-citationSimilar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion
Ilango, A., Kesner, A. J., Keller, K. L., Stuber, G. D., Bonci, A., & Ikemoto, S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1703-13.2014 · Cited by 255 · cited 1×
“Indeed, optogenetic activation or silencing of VTA dopamine neurons leads to rewarding or aversive responses, respectively (30), suggesting that silencing of “rewarding”VTADA neurons may lead to aversive responses.”
BackgroundGeorge, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 1×
“Many reports show that the neurotransmitter dopamine is crucial for the mediation of drug reward (1) and that other nondopaminergic neural substrates are responsible for the negative effects experienced after drug use (2, 3), although there is evidence that dopaminergic neurons can also be modulated by aversive stimul…”
BackgroundWalters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206
Cited by
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety
Nguyen, C., Mondoloni, S., Le Borgne, T., Centeno, I., Come, M., Jehl, J., Solié, C., Reynolds, L. M., Durand-de Cuttoli, R., Tolu, S., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.013 · Cited by 136
Self-citationLaviolette, S. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108411 · Cited by 57
Lakosa, A., Rahimian, A., Tomasi, F., Marti, F., Reynolds, L. M., Tochon, L., David, V., Danckaert, A., Canonne, C., Tahraoui, S., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01563-x · Cited by 10
Self-citation
Metadata
- Authors
- Grieder, T. E., Besson, M., Maal-Bared, G., Pons, S., Maskos, U., & van der Kooy, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2019-11-27
- Volume
- 116
- Issue
- 51
- Pages
- 25968-25973
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2991614103
- Cited by
- 36
- References
- 13
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward. https://app.cochat.ai/papers/10.1073/pnas.1908724116
- The paper
- Grieder, T. E., Besson, M., Maal-Bared, G., Pons, S., Maskos, U., & van der Kooy, D. (2019). β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1908724116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.